TP53 and hepatocellular carcinoma: Although hepatoma Hep3B and pancreatic AsPC-1 cells are p53-negative cancer cells (see Figure 2A), the basal level of TP53 mRNA increased relatively in these two cells, which explains the increased transcriptional levels of XAF1, CDKN1A, and MDM2.